Based on staff interview and record review, the facility did not ensure adequate monitoring and administration for 1 resident (R) (R7) of 3 sampled residents who received psychotropic medication. R7 had an order for clozapine 25 milligrams (mg) twice daily (BID) for psychosis related to Parkinson's disease and a weekly complete blood count (CBC) with differential (diff) for monitoring. On 11/19/24, staff did not ensure the correct lab was drawn. R7 did not receive clozapine from 11/23/24 to 11/26/24 and was sent to the emergency room (ER) on 11/26/24 for symptoms of psychosis. …
F758 citations in Wisconsin
Psychotropic drugs · Pharmacy Service Deficiencies
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Wisconsin cites F758 more often than its own record predicts
1.16 times the share F758 takes of citations nationally.
Of every deficiency written in Wisconsin in 2025, this is the portion that was F758.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Wisconsin surveyors wrote
F758 findings written in Wisconsin, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Based on interview and record review, the facility did not ensure adequate monitoring for adverse reactions/side effects of psychotropic medications, or behavior monitoring required for use of psychotropic medications for 1 (R1) of 6 residents reviewed for psychotropic medications. R1 does not have any behavior monitoring in place related to their use of psychotropic medication (Buspar). Findings include: R1 was admitted to the facility on [DATE] with diagnoses including anxiety disorder and major depression. R1's Quarterly MDS (Minimum Data Set) Assessment with an assessment reference date of 1/16/2025 indicates R1 received an antidepressant medication during the assessment period. …
The short window
Recent years
| Year | Share of Wisconsin citations | vs expected |
|---|---|---|
| 2023 | 3.06% | 1.85× |
| 2024 | 1.92% | 1.29× |
| 2025 | 0.73% | 1.16× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Wisconsin surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction